Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-95-002822
Filing Date
1995-10-06
Accepted
1995-10-06 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSON DEVELOPMENT CORP.JOHNSON & JOHNSON ET AL
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 34285
  Complete submission text file 0000950123-95-002822.txt   36135
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON ET AL (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42168 | Film No.: 95579073
SIC: 2834 Pharmaceutical Preparations